In tumor diseases, the high expression of Ghrelin is generally believed to activate the NF-κB signaling pathway, inhibit the expression of p53, and cause tumor cell proliferation and migration (Chen et al., 2011; Tian et al., 2013). This evidence concerns the gene NFKB1 and neoplasm.